In contrast, our finding that higher circulating C2 predicts increased incident MI risk (Table 3), may reflect differences between lifelong deficiency and elevated plasma levels, with the latter potentially indicating complement activation or inflammation. The gene discussed is C2; the disease is myocardial infarction.